FDA grants ’emergency use’ coronavirus test that can deliver results in 45 minutes
Diagnostics company Cepheid on Saturday said it has received emergency authorization from the U.S. Food and Drug Administration to use its rapid molecular test for point-of-care patients that can detect the virus that causes COVID-19 in 45 minutes.
This is the first coronavirus test that can be conducted entirely at the point-of-care for patients and deliver results in less than an hour. Typically, tests are sent to central reference labs that can take several days to deliver results. Cepheid said tests will begin to ship on Friday, March 27 with plans to roll it out by Monday, March 30.
“We are moving into a new phase of testing, where tests will be much more easily accessible to Americans who need them,” HHS Secretary Alex Azar said in statement Saturday.
FDA Commissioner Stephen Hahn added that “today marks an important step in expanding the availability of testing and, importantly, …continued .
[Source: CNBC News]